Companies

Roivant Sciences Ltd. (ROIV) SEC filings

CIK 0001635088 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in D0 · fiscal year ends 03/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Revenue (USD)8.3 M31.5 M
Net income (USD)-299.8 M-1.0 B
Diluted EPS (USD/shares)-0.54-1.42

Latest filings

FiledFormDescriptionPeriod
2026-10-218-K8-K items 7.01,9.012026-10-21
2026-10-204FORM 42026-10-16
2026-10-204FORM 42026-10-16
2026-10-20144144
2026-10-05SCHEDULE 13D/ASCHEDULE 13D/A
2026-10-054FORM 42026-10-01
2026-10-054FORM 42026-10-01
2026-10-024FORM 42026-09-30
2026-10-024FORM 42026-09-30
2026-10-024FORM 42026-09-30
2026-10-024FORM 42026-09-30
2026-09-30144144
2026-09-224FORM 42026-09-20
2026-09-224FORM 42026-09-20
2026-09-184FORM 42026-09-16
2026-09-184FORM 42026-09-16
2026-09-184FORM 42026-09-16
2026-09-184FORM 42026-09-16
2026-09-184FORM 42026-09-16
2026-09-184FORM 42026-09-16
2026-09-188-K8-K items 5.07,9.012026-09-16
2026-09-174FORM 42026-09-15
2026-09-174FORM 42026-09-15
2026-09-15144144
2026-09-15144144

Forms on file (last 1,000): 4 469, 144 179, 8-K 79, SC 13D/A 33, 3 31, 424B3 20, SCHEDULE 13G/A 19, SC 13G/A 19. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ROIV (0.002 USD), /gw/filings/filings?ticker=ROIV&form=8-K, /gw/filings/facts?ticker=ROIV&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange